Shares of Valeant Pharmaceuticals Int’l, Inc. (VRX) are higher by nearly 6 percent to $99.56 in pre-market trading on Tuesday after the embattled drugmaker announced a 20-year fulfillment agreement with Walgreens (WBA) under which it will offer 30+ drugs at generic prices.
Valeant said the agreement will enable consumers to conveniently access Valeant’s dermatology and ophthalmology products at a lower out-of-pocket cost from more than 8,000 Walgreens U.S. retail pharmacy locations, as well as participating independent retailers.
The 20-year agreement takes effect the first quarter of 2016.
—
Shares of Nvidia Corporation (NVDA) are up 3.38% this morning on news the company was unsuccessful in its appeal before the International Trade Commission in a patent case against Samsung Electronics and Qualcomm Inc (QCOM).
Nvidia had accused both companies of using its patents on graphics chip technology without permission or compensation.
—
Shares of Kitov Pharmaceuticals Holdings LTD (KTOV) are up 45 percent in pre-market hours following the company’s announcement that the Phase III clinical trial for KIT-302 successfully met the primary efficacy endpoint of the trial protocol as approved by the FDA.
—
Lumber Liquidators Holdings, Inc. (LL) spikes 27% to $17.84 in pre-market trade after short-seller Whitney Tilson announced in an article written in SeekingAlpha.com he has covered his short. Tilson had said LL would likely go to zero.
Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!
Leave a Reply